Slug and E-Cadherin: Stealth Accomplices?
- PMID: 32760736
- PMCID: PMC7371942
- DOI: 10.3389/fmolb.2020.00138
Slug and E-Cadherin: Stealth Accomplices?
Abstract
During physiological epithelial-mesenchymal transition (EMT), which is important for embryogenesis and wound healing, epithelial cells activate a program to remodel their structure and achieve a mesenchymal fate. In cancer cells, EMT confers increased invasiveness and tumor-initiating capacity, which contribute to metastasis and resistance to therapeutics. However, cellular plasticity that navigates between epithelial and mesenchymal states and maintenance of a hybrid or partial E/M phenotype appears to be even more important for cancer progression. Besides other core EMT transcription factors, the well-characterized Snail-family proteins Snail (SNAI1) and Slug (SNAI2) play important roles in both physiological and pathological EMT. Often mentioned in unison, they do, however, differ in their functions in many scenarios. Indeed, Slug expression does not always correlate with complete EMT or loss of E-cadherin (CDH1). For example, Slug plays important roles in mammary epithelial cell progenitor cell lineage commitment and differentiation, DNA damage responses, hematopoietic stem cell self-renewal, and in pathologies such as pulmonary fibrosis and atherosclerosis. In this Perspective, we highlight Slug functions in mammary epithelial cells and breast cancer as a "non-EMT factor" in basal epithelial cells and stem cells with focus reports that demonstrate co-expression of Slug and E-cadherin. We speculate that Slug and E-cadherin may cooperate in normal mammary gland and breast cancer/stem cells and advocate for functional assessment of such Slug+/E-cadherinlow/+ (SNAI2+/CDH1low/+) "basal-like epithelial" cells. Thus, Slug may be regarded as less of an EMT factor than driver of the basal epithelial cell phenotype.
Keywords: E-cadherin (CDH1); Slug (SNAI2); basal; breast cancer; epithelial-mesenchymal transition (EMT); luminal; mammary gland.
Copyright © 2020 Sterneck, Poria and Balamurugan.
Figures
Similar articles
-
Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis.PLoS One. 2012;7(12):e53498. doi: 10.1371/journal.pone.0053498. Epub 2012 Dec 27. PLoS One. 2012. PMID: 23300933 Free PMC article.
-
Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.Med Mol Morphol. 2017 Jun;50(2):68-75. doi: 10.1007/s00795-016-0149-0. Epub 2016 Dec 19. Med Mol Morphol. 2017. PMID: 27995335
-
SLUG: Critical regulator of epithelial cell identity in breast development and cancer.Cell Adh Migr. 2014;8(6):578-87. doi: 10.4161/19336918.2014.972740. Cell Adh Migr. 2014. PMID: 25482617 Free PMC article. Review.
-
Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis.Hum Pathol. 2018 Dec;82:149-157. doi: 10.1016/j.humpath.2018.07.018. Epub 2018 Jul 29. Hum Pathol. 2018. PMID: 30067950
-
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.Mol Cancer. 2016 Feb 24;15:18. doi: 10.1186/s12943-016-0502-x. Mol Cancer. 2016. PMID: 26905733 Free PMC article. Review.
Cited by
-
Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.Animals (Basel). 2023 Feb 28;13(5):878. doi: 10.3390/ani13050878. Animals (Basel). 2023. PMID: 36899736 Free PMC article.
-
Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance.Cancer Metastasis Rev. 2022 Mar;41(1):131-145. doi: 10.1007/s10555-021-10003-5. Epub 2022 Jan 3. Cancer Metastasis Rev. 2022. PMID: 34978017 Review.
-
Reversely immortalized mouse salivary gland cells presented a promising metabolic and fibrotic response upon BMP9/Gdf2 stimulation.Cell Mol Biol Lett. 2022 Jun 11;27(1):46. doi: 10.1186/s11658-022-00333-9. Cell Mol Biol Lett. 2022. PMID: 35690719 Free PMC article.
-
TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer.Curr Issues Mol Biol. 2023 May 24;45(6):4529-4543. doi: 10.3390/cimb45060287. Curr Issues Mol Biol. 2023. PMID: 37367036 Free PMC article.
-
Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype.Front Immunol. 2021 Dec 15;12:797261. doi: 10.3389/fimmu.2021.797261. eCollection 2021. Front Immunol. 2021. PMID: 34975907 Free PMC article.
References
-
- Alves C. L., Elias D., Lyng M. B., Bak M., Ditzel H. J. (2018). SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer. Breast Cancer Res. 20:60. 10.1186/s13058-018-0988-9 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous